Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines

被引:116
作者
Bloethner, S
Chen, BW
Hemminki, K
Müller-Berghaus, J
Ugurel, S
Schadendorf, D
Kumar, R
机构
[1] German Canc Res Ctr, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany
[2] Karolinska Inst, Dept Biosci, S-14157 Huddinge, Sweden
[3] German Canc Res Ctr, Skin Canc Unit, D-69120 Heidelberg, Germany
关键词
D O I
10.1093/carcin/bgi066
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We studied global gene expression in three melanoma cell lines with the most common and potent V600E mutation in the B-RAF gene-four cell lines with a common Q61R mutation in the N-RAS gene and three cell lines with no mutations using human HG-U133A 2.0 micro-arrays with 22 277 transcripts. Data analysis using stringent criteria revealed several upregulated and downregulated genes in cell lines with B-RAF and N-RAS mutations compared with cell lines without mutations. We found 29 genes specifically upregulated and 32 genes downregulated in cell lines with B-RAF mutations, whereas 70 genes were upregulated and 39 downregulated in cell lines with N-RAS mutations; 11 genes showed overlapping upregulation and 45 down-regulation. The micro-array data for nine selected genes were validated by the real-time PCR technique. Expression of a large number of genes, that encode members or regulators of the RAS/RAF/MEK/ERK pathways or are involved in metastasis or invasion, was affected in cell lines with mutations in B-RAF and N-RAS. Upregulated genes in cell lines with mutations included dual-specificity phosphatase 6 (DUSP6), sprouty 2 (SPRY2), v-akt murine thymoma viral oncogene homolog 3 (AKT3) and matrix metalloproteinase 14 (MMP14); downregulated genes included interleukin 18 (IL18), Kruppel-like factor 5 (KLF5) and inhibitor of DNA binding 2 (ID2). Our results, though carried on cell lines, provide a novel insight into the effect of mutations in the B-RAF and N-RAS genes on global gene expression in melanoma and highlight the complexity of mechanisms involved in tumour initiation and maintenance.
引用
收藏
页码:1224 / 1232
页数:9
相关论文
共 34 条
[11]   Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth [J].
Iida, J ;
Wilhelmson, KL ;
Price, MA ;
Wilson, CM ;
Pei, DQ ;
Furcht, LT ;
McCarthy, JB .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (01) :167-176
[12]   TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins [J].
Kanai, F ;
Marignani, PA ;
Sarbassova, D ;
Yagi, R ;
Hall, RA ;
Donowitz, M ;
Hisaminato, A ;
Fujiwara, T ;
Ito, Y ;
Cantley, LC ;
Yaffe, MB .
EMBO JOURNAL, 2000, 19 (24) :6778-6791
[13]  
Kristiansen G, 2004, J MOL HISTOL, V35, P255
[14]   Activating BRAF and N-Ras mutations in sporadic primary melanomas:: an inverse association with allelic loss on chromosome 9 [J].
Kumar, R ;
Angelini, S ;
Hemminki, K .
ONCOGENE, 2003, 22 (58) :9217-9224
[15]  
Kumar R, 2003, CLIN CANCER RES, V9, P3362
[16]   BRAF mutations are common somatic events in melanocytic nevi [J].
Kumar, R ;
Angelini, S ;
Snellman, E ;
Hemminki, K .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (02) :342-348
[17]   Gene transfer of secreted-type modified interleukin-18 gene to B16F10 melanoma cells suppresses in vivo tumor growth through inhibition of tumor vessel formation [J].
Nagai, H ;
Hara, I ;
Horikawa, T ;
Oka, M ;
Kamidono, S ;
Ichihashi, M .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (03) :541-548
[18]   ETS transcription factors: Possible targets for cancer therapy [J].
Oikawa, T .
CANCER SCIENCE, 2004, 95 (08) :626-633
[19]  
Omholt K, 2002, CLIN CANCER RES, V8, P3468
[20]   Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation [J].
Palacios, EH ;
Weiss, A .
ONCOGENE, 2004, 23 (48) :7990-8000